A commonly used over-the-counter anti-inflammatory drug and a herbal product may provide alternative options for treating urinary tract infection, one of the most common conditions in adult women which is currently treated with antibiotics, say researchers.
With antibiotic resistance rising, reducing the use of antibiotics where possible is one of the top priorities among health professionals.
To assess the effectiveness of the anti-inflammatory drug and the herbal product called Uva ursi, the researchers from University of Southampton will study the response of these mediations on 300 women with suspected cystitis (urinary tract infection).
"We are really excited to be getting started with this study which hopes to identify ways of relieving symptoms of urinary infection without the need to resort to antibiotics" lead researcher Michael Moore, professor at University of Southampton said in a statement released by the university.
Uva ursi, also known as bearberry or bear's grape, is a plant found in North America, Asia and northern Europe. The herbal product is extracted from the leaves of the Uva ursi plant and has reported diuretic, urinary antiseptic and anti-inflammatory properties.
Uva ursi has a traditional use dating back to the middle ages for many conditions including cystitis, urethritis and dysuria.
However, the efficacy of Uva ursi treatment in humans remains unproven, despite long-term use in folk medicine.
The new clinical trial was developed to find out if either Uva ursi or a readily available anti-inflammatory drug can be used during a period of delayed antibiotic prescription to provide symptom relief.
If so they would have the potential to change the way treatment is given and be used as an alternative to antibiotic prescribing.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
